Nymox Pharmaceutical Corporation
NYMXF
$0.0751
-$0.0049-6.13%
OTC PK
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 12/31/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 74.00K | 41.00K | 70.00K | 70.00K | 132.00K |
| Total Receivables | 27.00K | 23.00K | 11.00K | 11.00K | 10.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.00K | 23.00K | 16.00K | 16.00K | 44.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 536.00K | 536.00K | 528.00K | 528.00K | 28.00K |
| Total Current Assets | 653.00K | 623.00K | 625.00K | 625.00K | 214.00K |
|
|
|||||
| Total Current Assets | 653.00K | 623.00K | 625.00K | 625.00K | 214.00K |
| Net Property, Plant & Equipment | 1.00K | 1.00K | 2.00K | 2.00K | 57.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 654.00K | 624.00K | 627.00K | 627.00K | 271.00K |
|
|
|||||
| Total Accounts Payable | 4.12M | 4.31M | 3.02M | 3.02M | 2.34M |
| Total Accrued Expenses | 28.00K | -- | 27.00K | 27.00K | -- |
| Short-term Debt | 3.29M | 2.61M | 750.00K | 750.00K | 750.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 55.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.43M | 6.92M | 3.80M | 3.80M | 3.15M |
|
|
|||||
| Total Current Liabilities | 7.43M | 6.92M | 3.80M | 3.80M | 3.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.29M | 2.61M | 750.00K | 750.00K | 750.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.43M | 6.92M | 3.80M | 3.80M | 3.15M |
|
|
|||||
| Common Stock & APIC | 201.89M | 201.60M | 201.60M | 201.60M | 198.76M |
| Retained Earnings | -212.47M | -211.62M | -207.98M | -207.98M | -201.64M |
| Treasury Stock & Other | 3.81M | 3.72M | 3.21M | 3.21M | -- |
| Total Common Equity | -6.78M | -6.30M | -3.17M | -3.17M | -2.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.78M | -6.30M | -3.17M | -3.17M | -2.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.78M | -6.30M | -3.17M | -3.17M | -2.88M |
|
|
|||||